Production (Stage)
Cumberland Pharmaceuticals Inc.
CPIX
$3.91
$0.4111.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 166.03% | -23.30% | -42.23% | 44.22% | 69.08% |
| Total Depreciation and Amortization | -26.09% | 27.15% | -1.64% | -0.79% | 5.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 149.36% | 44.04% | -472.75% | 46.68% | -107.58% |
| Change in Net Operating Assets | -53.50% | 82.25% | 224.36% | 23.17% | -148.05% |
| Cash from Operations | 104.69% | 300.55% | 155.57% | 59.95% | -305.42% |
| Capital Expenditure | -1,969.57% | 85.06% | -113.89% | 82.69% | 14.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4,718.78% | -111.95% | 617.68% | -138.55% | -105.37% |
| Cash from Investing | -4,482.84% | -114.14% | 505.13% | 19.59% | -122.33% |
| Total Debt Issued | -- | -49.95% | -0.10% | 0.00% | 42.86% |
| Total Debt Repaid | -58.90% | 42.53% | 0.03% | -42.76% | 1.77% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -149.90% | 0.40% | 26.38% | 45.80% | -31.01% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.01% | -6.07% | -139.61% | 71.02% | 45.59% |
| Cash from Financing | -300.91% | -156.78% | -73.39% | -112.78% | 262.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -671.85% | 289.24% | 110.59% | -634.16% | 221.79% |